• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Gene therapy with BMP4 protects against weight gain and insulin…

Bioengineer.org by Bioengineer.org
January 29, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Photo: Michael Frietsch

"By increasing BMP4, we can increase the metabolic rate, but we only see this in initially lean mice. Overweight mice proved to have a BMP4 resistance, which is also an important finding," says Jenny Hoffmann, first author of the article and active at the Lundberg Laboratory for Diabetes Research.

She recently earned her PhD in medicine with a thesis focused on BMP4, Bone Morphogenetic Protein 4, and how it regulates white, beige and brown fat in the body. White fat cells store and release fat, brown fat cells burn fat and produce heat, and beige fat cells, which are located within the white fat, can burn fat upon activation. BMP4 has important functions during fetal development, but has proven to play an especially important role in the development of fat cells.

In one of the studies, cells from human fat biopsies were used and the other two studies used adult mice that were given BMP4 gene therapy. In the current study, the mice were given a high-fat, more energy-rich diet, at the same time that they were injected with a harmless virus that carried BMP4, which targets the liver and spreads from there.

"In mice that were initially lean, we see that the white fat becomes more beige and metabolically active, while the brown fat becomes "whiter". So there's a negative effect on the brown fat and a positive effect on the white fat, but the positive outweighs the negative and the mice have improved metabolic health. They are protected from weight gain and do not get insulin resistance, a marker for risk of Type-2 diabetes," says Jenny Hoffmann.

Mice that were overweight from the beginning reacted differently. Gene therapy with BMP4 gave no protection from further weight gain, but they were protected from insulin resistance with increased energy intake. The overweight animals, which proved to have higher levels of their own BMP4 protein, also had high levels of so-called antagonists, which prevented the BMP4 signaling in the fat. In other words, they were resistant to the effects of BMP4 in terms of the positive effects on beige fat cells.

The fat tissue is important as a repository for excess energy. Primarily, the subcutaneous fat expands. Then, fat begins to be stored at less healthy places – in the abdomen, liver and muscles. According to Jenny Hoffmann, identifying the effect of the BMP4 protein can be an important target in the struggle against Type-2 diabetes, cardiovascular disease and other illnesses linked to obesity.

"This is basic research," she emphasizes, "but greater understanding of BMP4 signaling in fat can lead to new therapeutic possibilities for obesity and Type-2 diabetes."

###

Link to the article: http://www.cell.com/cell-reports/fulltext/S2211-1247(17)30979-8

Link to the thesis: http://hdl.handle.net/2077/51876

Author: Jenny Hoffmann +46 (0)709 61 52 89; [email protected]

Photographs: Michael Frietsch

Press contact: Margareta Gustafsson Kubista +46 (0)705 30 19 80; [email protected]

Media Contact

Jenny Hoffmann
[email protected]
46-070-961-5289
@uniofgothenburg

http://www.gu.se/english

Original Source

http://www.gu.se/english/about_the_university/news-calendar/News_detail/?languageId=100001&contentId=1507534&disableRedirect=true&returnUrl=http%3A%2F%2Fwww.gu.se%2Fomuniversitetet%2Faktuellt%2Fnyheter%2Fdetalj%2F%2Fgenterapi-som-skyddar-mot-viktokni http://dx.doi.org/10.1016/j.celrep.2017.07.020

Share12Tweet7Share2ShareShareShare1

Related Posts

Participant Insights from the Navigate-Kidney Study on Kidney Failure Care Intervention

Participant Insights from the Navigate-Kidney Study on Kidney Failure Care Intervention

November 8, 2025

Global Prevalence of Chronic Kidney Disease More Than Doubles Since 1990, Impacting Nearly 800 Million People

November 8, 2025

Chronic Kidney Disease Rises to Ninth Leading Cause of Death, New Data Reveals

November 8, 2025

New App Assesses Impaired Vigilance Through Digital Tools

November 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    314 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1302 shares
    Share 520 Tweet 325
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Participant Insights from the Navigate-Kidney Study on Kidney Failure Care Intervention

Global Prevalence of Chronic Kidney Disease More Than Doubles Since 1990, Impacting Nearly 800 Million People

Chronic Kidney Disease Rises to Ninth Leading Cause of Death, New Data Reveals

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.